Prognostic value of androgen receptor and FOXA1 co-expression in non-metastatic triple negative breast cancer and correlation with other biomarkers-Reference-Cited by-同舟云学术

Prognostic value of androgen receptor and FOXA1 co-expression in non-metastatic triple negative breast cancer and correlation with other biomarkers

Published:2018-06-08 Issue:1 Volume:119 Page:76-79
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Guiu Séverine,Mollevi Caroline,Charon-Barra Céline,Boissière Florence,Crapez Evelyne,Chartron Elodie,Lamy Pierre-Jean,Gutowski Marian,Bourgier Céline,Romieu Gilles,Simony-Lafontaine Joelle,Jacot William

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/s41416-018-0142-6.pdf

Reference11 articles.

1. Lehmann, B. D. et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J. Clin. Investig. 121, 2750–2767 (2011).

2. McNamara, K. M. et al. Androgen receptor in triple negative breast cancer. J. Steroid Biochem. Mol. Biol. 133, 66–76 (2013).

3. Qu, Q., Mao, Y., Fei, X. C. & Shen, K. W. The impact of androgen receptor expression on breast cancer survival: a retrospective study and meta-analysis. PloS One 8, e82650 (2013).

4. Wang, C. et al. Prognostic value of androgen receptor in triple negative breast cancer: a meta-analysis. Oncotarget 7, 46482–46491 (2016).

5. Lehmann, B. D. et al. PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors. Breast Cancer Res.: BCR 16, 406 (2014).

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of New Chemoresistance-Associated Genes in Triple-Negative Breast Cancer by Single-Cell Transcriptomic Analysis;International Journal of Molecular Sciences;2024-06-22

2. Network-based approach elucidates critical genes in BRCA subtypes and chemotherapy response in triple negative breast cancer;iScience;2024-05

3. Treatments Targeting the Androgen Receptor and Its Splice Variants in Breast Cancer;International Journal of Molecular Sciences;2024-02-02

4. Is the Androgen Receptor a Viable Target in Triple Negative Breast Cancer in 5 Years?;Clinical Breast Cancer;2023-12

5. AGR2 and FOXA1 as prognostic markers in ER-positive breast cancer;BMC Cancer;2023-08-11